Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStopping Mounjaro without gaining weight is a real clinical challenge, and being honest about that matters. Tirzepatide suppresses appetite through two gut-hormone pathways; when those signals quieten, hunger typically returns — sometimes sharply. The decision to wean off involves weighing up why you're stopping, what you've built during treatment, and how to protect that progress afterwards. These are conversations worth having with your prescriber rather than decisions made alone, because the right approach depends on your individual health picture. Mounjaro is a prescription-only medicine and any plan to reduce or stop it should be clinically guided.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide works by activating two receptors (GIP and GLP-1) that regulate appetite, slow how quickly food leaves your stomach, and influence how the brain reads fullness signals. Whilst you're on it, many people find their relationship with food feels genuinely different: smaller portions feel satisfying, cravings ease. Stop the medicine and those receptor signals fade, usually within a few weeks.
The result for most people is a gradual return of pre-treatment hunger patterns. That's biology, not failure. The NHS medicines page on tirzepatide notes that treatment is intended to be used alongside long-term lifestyle change for precisely this reason, the medicine supports the work, but the work has to persist beyond it.
Expecting hunger to stay suppressed without the medicine is the most common misconception people carry into stopping. Letting go of that expectation, gently, is actually the most practical first step. If you've been gaining weight on Mounjaro near the end of treatment, it's worth understanding whether that's a sign of tolerance, lifestyle drift, or something else before you stop.
Abrupt stopping isn't medically dangerous in most cases, but it does remove the appetite buffer all at once. A slower, stepwise reduction (under prescriber guidance) gives your habits time to hold without the medicine's full effect behind them.
No supplement, trick, or protocol replaces what happens at the plate and in the gym. That said, there are specific habits that evidence and clinical experience consistently point to.
Protein is the most important single dietary variable. Higher protein intake supports satiety, preserves muscle mass during a calorie deficit, and reduces the likelihood of eating past fullness when hunger returns. Aim to make it the anchor of every main meal rather than an afterthought. The NHS England guidance on weight-management injections emphasises that lifestyle support (including diet) is integral to treatment, not optional.
Strength training matters too, more than most people realise. GLP-1 class medicines can cause some loss of lean muscle alongside fat, particularly at higher doses or with rapid weight loss. Resistance exercise (bodyweight, bands, weights, whatever you'll actually do consistently) helps preserve that muscle. More muscle means a higher resting metabolism, which makes the post-stopping period more forgiving.
Fibre, hydration, sleep and stress management all play supporting roles. They're not dramatic, but they compound. If you're looking at options beyond Mounjaro for longer-term weight management, it's worth reading about losing weight without Mounjaro as a grounding reference.
None of this is about perfection. A sustainable pattern beats an aggressive short-term plan every time.
This is the real decision, and it's genuinely clinical. There are broadly three situations people find themselves in when they consider stopping Mounjaro.
First: you've reached your goal weight and feel ready to maintain without medication. Second: you're stopping for a practical reason, cost, a planned pregnancy, surgery, or a temporary break. Third: the medicine isn't working as expected, or side effects are making it difficult to continue. Each situation calls for a different approach.
A taper (reducing dose stepwise before stopping) is sometimes suggested to give habits time to adjust, though the evidence base for a specific tapering protocol in healthy adults is limited. What matters more is that you don't stop before the lifestyle foundations are solid. Your prescriber is the right person to judge this, they have your history, your dose trajectory, and your health context in front of them.
If cost is part of the calculation, it's worth understanding what a full private prescription service includes before making the decision, because the components that look expensive individually often cover more than expected. Stopping prematurely to save money, only to regain weight and restart, costs more in the end, practically and personally.
For a detailed walkthrough of the stopping process itself, the guide on how to wean off Mounjaro covers the practical steps. And if regain does happen, understanding why weight returns after Mounjaro can help you respond without panic.
Some regain in the weeks after stopping is common and not a signal that everything has failed. The body resets fluid balance, gut motility shifts, and appetite recalibrates. Give it time before drawing conclusions.
If regain continues beyond the first few weeks, the first question is whether your lifestyle habits have drifted or whether hunger is simply overwhelming them. These have different solutions. Drifted habits can often be corrected with intention. Persistent biological hunger may be a sign that the underlying condition (obesity) is not yet in long-term remission, and that continuing or restarting treatment is a legitimate clinical option rather than a personal setback.
Restarting at the lowest dose after a break is a recognised approach; your prescriber can advise on timing and whether it makes sense given your situation. The tirzepatide overview covers the broader clinical picture for context. If you want to understand all your weight management options in one place, the weight-loss treatment overview is a good starting point.
Speak to our team at any point. Prescriber support doesn't end when you stop treatment, it's part of what aftercare is for.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.